AhmadOzairMD(he/him)

Summary

• Ahmad Ozair is a postdoctoral research fellow in neurosurgery at the University of Maryland School of Medicine in Baltimore, MD. He is also a Clarendon Scholar (awarded to the top 1% of graduate students at the University of Oxford) for Oxford's MSc in Evidence-Based Healthcare (EBHC) course.
  Ahmad is an incoming neurosurgery resident at McGill University (Montreal Neurological Institute).
  
  He completed medical school from India (2016-2022), graduating as the first-ranked candidate in a class of 250 from one of the top ten nationally ranked medical schools. During this, he completed several sub-internships in neurosurgery in the US, along with the Khorana Scholarship funded by the Government of India. He was one of the five students in the university's history (till 2022) who received all three of the most prestigious honors of the institution, along with being the sole inaugural recipient of the medical student research award. He also completed the Global Clinical Scholars Research Training (GCSRT, http://hms.harvard.edu/gcsrt) from HMS Post-Graduate Medical Education.
  
  He pursued a postdoctoral research fellow (2022-2023) in neuro-oncology at the Miami Cancer Institute, under Prof. Manmeet Ahluwalia & Prof. Michael McDermott in early-phase trials, including efforts through the Adult Brain Tumor Consortium. Thereafter, he moved to Johns Hopkins University to pursue an MPH, concentration in epidemiology-biostatistics, with a graduate certificate in 'clinical trials'. Here, he was 1/14 Sommer Scholars worldwide (>$100,000 scholarship).
  
  Currently, he is working under Prof. Graeme Woodworth, Professor and Chair of the Department of Neurosurgery at the University of Maryland. His published works span 100+ papers with 2000+ citations. He serves as a member of the EBM Committee and Clinical Guidelines Committee of the North American Spine Society (NASS). Finally, he serves as part of Workforce Workgroup for the inaugural Maryland Commission on Public Health.
Google Scholar
100+ publications and 2000+ citations.

Early Data Shows Potential of Surgically Targeted Radiation Therapy in GBM
In an interview with Targeted Oncology, Ahmad Ozair discussed a trial evaluating surgically targeted radiation therapy (START) for recurrent glioblastoma.
Web of Science
Research Portfolio